🧫
Phase I trial of NP137 in advanced endometrial cancer
active
experiment
Created: 2026-04-10T14:41:11
By: experiment_extractor
Quality:
95%
✓ SciDEX
ID: experiment-exp-0854c675-3027-47a4-971e-0
🧫 Experiment Protocol
Clinical Trialproposed
N = 14
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T14:41:11.364750'} |
| p_value | None |
| protocol | Phase I dose-escalation trial with NP137 monotherapy |
| effect_size | 57.1% stable disease rate, 7.1% objective response rate |
| sample_size | 14 |
| source_pmid | 37532934 |
| extracted_at | 2026-04-10T07:41:11.301545 |
| _schema_version | 1 |
| experiment_type | clinical_trial |
| success_criteria | Objective response rate and stable disease achievement |
| expected_outcomes | Demonstrated safety and clinical activity in advanced EC |
| statistical_methods | RECIST v.1.1 response criteria |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
70%
Debates
0
Incoming
14
Outgoing
11
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.